Puma Biotechnology PBYI
NASDAQ PBYI
$9.93 +0.15 (+1.53%)
At close: Sep 30, 2026 · 4:00 PM EDT

Puma Biotechnology (PBYI) Research & Development (2012 - 2026)

Updated

Puma Biotechnology's Research & Development came in at $18.9 million for Q2 2026, up 22.3% from $15.45 million a year earlier but down 4.5% from the prior quarter.

Analysis

Puma Biotechnology (PBYI) Research & Development (2012 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Puma Biotechnology reported Research & Development of $71.44 million, up 25.3% year-over-year; for FY2025, it was $62.07 million, up 13.0% from FY2024.

  • Research & Development carries a five-year compound annual growth rate of -8.7% (FY2020 to FY2025).
  • Going back by year, Research & Development was $54.94 million in FY2024 (+9.0%), $50.38 million in FY2023 (-3.6%), $52.24 million in FY2022 (-27.3%) and $71.87 million in FY2021 (-26.4%).
  • The five-year range for quarterly Research & Development is $11.25 million (Q3 2022) to $19.8 million (Q1 2026).
  • Year-over-year, Research & Development has increased for ten consecutive quarters, with growth averaging 18.2% over the last eight quarters.
  • The fastest year-over-year change in Research & Development over five years came in Q1 2026 (growth of 42.8%), and the weakest in Q4 2021 (a decline of 41.4%).
  • Business Quant data shows PBYI's Research & Development at $19.8 million (Q1 2026), $16.84 million (Q4 2025) and $15.91 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 3.65 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 2.34 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -2.85 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -4.05 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 1.87 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 1.76 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.81 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 993.80 Mn
10 Puma Biotechnology 499.78 Mn 112.42 Mn 44.03 Mn 18.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.90 Mn
Mar 31, 2026 19.80 Mn
Dec 31, 2025 16.84 Mn
Sep 30, 2025 15.91 Mn
Jun 30, 2025 15.45 Mn
Mar 31, 2025 13.86 Mn
Dec 31, 2024 15.17 Mn
Sep 30, 2024 12.55 Mn
Jun 30, 2024 13.63 Mn
Mar 31, 2024 13.59 Mn
Dec 31, 2023 12.87 Mn
Sep 30, 2023 11.45 Mn
Jun 30, 2023 13.36 Mn
Mar 31, 2023 12.71 Mn
Dec 31, 2022 13.78 Mn
Sep 30, 2022 11.25 Mn
Jun 30, 2022 11.97 Mn
Mar 31, 2022 15.24 Mn
Dec 31, 2021 14.17 Mn
Sep 30, 2021 18.84 Mn
API Access

Puma Biotechnology Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=PBYI&period=max&api_key=YOUR_API_KEY